Company Name
Astellas Venture Management LLC

Established
September 22, 2005

Owner
Astellas US Holding Inc.

Business
Investment in emerging biotechnology companies, Astellas Venture Management LLC (AVM) is the corporate venture capital arm of Astellas Pharma Inc., a global pharmaceutical company originated in Japan. The venture capital activity of AVM can trace back to Astellas Venture Capital LLC (originally founded as Yamanouchi VentureCapital LLC in 2000) and Fujisawa Investments for Entrepreneurship LP established in 1999. AVM is currently managing four funds.

Parent Company Information
Astellas Pharma Inc., the ultimate parent company of Astellas Venture Management headquartered in Tokyo, was created on April 1, 2005, by the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd. The company is one of the top pharmaceutical companies in Japan in terms of sales, R&D investment and the number of medical representatives. In addition to the competitive edge established in the disease areas of Urology and Inflammation/Immunology, Astellas has strong interest in the fields of CNS, Pain, Diabetes/Metabolic disease, Anti-infectives (anti-viral) and Cancer.